Athos Therapeutics develops artificial intelligence-based precision therapeutics for patients with autoimmune diseases and cancer.

Athos Therapeutics

Developing precision therapeutics for patients with chronic inflammatory diseases incorporating artificial intelligence and machine learning algorithms

Athos Therapeutics Inc

Announcing the future of secure, scalable AI Cloud infrastructure: Athos Therapeutics Inc taps Vultr Cloud GPU to power AI drug discovery engine - powered by NVIDIA and running on #Dell #PowerEdge servers: https://dell.to/3KSej6D #TransformHIT Dell Technologies Dell Technologies Partner

Athos has exciting news to share regarding our Artificial Intelligence Development!

Read more below: 

https://lnkd.in/gD3icA3y

Athos Therapeutics participated in the J.P Morgan Conference in Abu Dhabi, organized by the United Al Saqer Group, Blue Horizon Advisors, and the J.P. Morgan Life Sciences Private Capital Team. 

Athos CEO, Dr. DIMITRIOS ILIOPOULOS  participated in an exciting panel discussion related to the emerging biotech hub in Abu Dhabi.

We're #hiring a new Executive Assistant in Torrance, California. Apply today or share this post with your network.

We're #hiring a new Information Technology Engineer in Torrance, California. Apply today or share this post with your network.

We're #hiring a new Director, Preclinical Toxicology & Regulatory Affairs in Los Angeles, California. Apply today or share this post with your network.

Metric
Company Name	Athos Therapeutics
Symbol
MSH ID	COM:ATHOSTX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	28
Website	athostx.com
LinkedIn	athostx
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ATHOSTX

Athos Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue